{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:48:32Z","timestamp":1747928912405,"version":"3.37.3"},"reference-count":56,"publisher":"Informa UK Limited","issue":"5","funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2024,5,3]]},"DOI":"10.1080\/03007995.2024.2318004","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T09:34:44Z","timestamp":1710495284000},"page":"813-820","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Addressing hepatitis delta in primary care practices in the US: a narrative review"],"prefix":"10.1080","volume":"40","author":[{"given":"Tatyana","family":"Kushner","sequence":"first","affiliation":[{"name":"Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Texas Clinic Westview, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2024,4,14]]},"reference":[{"key":"e_1_3_5_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890270107"},{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2016.126"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323888"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104812"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021576"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13556"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a021550"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goz023"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.030"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.052"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v13.i3.291"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz001"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.04.025"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2018.03.013"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/hc9.0000000000000168"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2870-z"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2014.72"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.08.019"},{"key":"e_1_3_5_20_1","first-page":"148A","article-title":"Low adherence to guidelines recommendation for testing hepatitis D in HBsAg positive patients leads to a high rate of undiagnosis","volume":"74","author":"Palom A","year":"2021","unstructured":"Palom A, Rando-Segura A, Riveiro-Barciela M, et\u00a0al. Low adherence to guidelines recommendation for testing hepatitis D in HBsAg positive patients leads to a high rate of undiagnosis. Hepatology. 2021;74:148A\u2013149A.","journal-title":"Hepatology"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.008"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316601"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz633"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i18.2127"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa001"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000000954"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.019"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14833"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-317874"},{"key":"e_1_3_5_31_1","unstructured":"World Health Organization. Hepatitis D fact sheet. [Internet]. 2022. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-d."},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7113a1"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr7201a1"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6701a1"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1323628"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2010.02320.x"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16807"},{"issue":"21","key":"e_1_3_5_40_1","first-page":"285","article-title":"Postexposure prophylaxis of hepatitis B","volume":"33","author":"Centers for Disease Control","year":"1984","unstructured":"Centers for Disease Control. Postexposure prophylaxis of hepatitis B. MMWR Morb Mortal Wkly Rep. 1984;33(21):285\u2013290.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.12525"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2020.11.052"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27837"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1508660"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14356"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.017"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0912696"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27102"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0618-8278(19)30058-1"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.12.018"},{"key":"e_1_3_5_51_1","unstructured":"Hepcludex. Summary of product characteristics. Gilead Sciences Ireland UC. 2021."},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1473-3099(22)00318-8"},{"issue":"2","key":"e_1_3_5_53_1","first-page":"S291","article-title":"Safety and efficacy of bulevirtide monotherapy and in combination with peginterferon alpha-2a in patients with chronic hepatitis delta: 24 weeks interim data of MYR204 phase 2b study","volume":"75","author":"Asselah T","year":"2021","unstructured":"Asselah T, Arama S, Bogomolov P, et\u00a0al. Safety and efficacy of bulevirtide monotherapy and in combination with peginterferon alpha-2a in patients with chronic hepatitis delta: 24 weeks interim data of MYR204 phase 2b study. J Hepatol. 2021;75(2):S291.","journal-title":"J Hepatol"},{"key":"e_1_3_5_54_1","first-page":"S294","article-title":"Bulevirtide monotherapy at low and high doses in patients with chronic hepatitis delta: 24-week interim data of the phase 3 MYR301 study","volume":"75","author":"Wedemeyer H","year":"2021","unstructured":"Wedemeyer H, Aleman S, Andreone P, et\u00a0al. Bulevirtide monotherapy at low and high doses in patients with chronic hepatitis delta: 24-week interim data of the phase 3 MYR301 study. J Hepatol. 2021;75:S294\u2013S803.","journal-title":"J Hepatol"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(23)04186-0"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00074-2"},{"key":"e_1_3_5_57_1","unstructured":"Eiger announces both lonafarnib-based treatments in pivotal phase 3 D-LIVR trial in hepatitis delta virus (HDV) achieved statistical significance against placebo in composite primary endpoint. CISION PR Newswire; 2022."}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2024.2318004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T19:04:08Z","timestamp":1727204648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2024.2318004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,14]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5,3]]}},"alternative-id":["10.1080\/03007995.2024.2318004"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2024.2318004","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"type":"print","value":"0300-7995"},{"type":"electronic","value":"1473-4877"}],"subject":[],"published":{"date-parts":[[2024,4,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-08-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-31","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-14","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}